Trials / Not Yet Recruiting
Not Yet RecruitingNCT06742255
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stellate Ganglion Block | Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment |
Timeline
- Start date
- 2024-12-20
- Primary completion
- 2024-12-20
- Completion
- 2024-12-20
- First posted
- 2024-12-19
- Last updated
- 2024-12-19
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06742255. Inclusion in this directory is not an endorsement.